Abstract:While marine natural products have been investigated for anticancer drug discovery, they are barely screened against rare cancers. Thus, in our effort to discover potential drug leads against the rare cancer pseudomyxoma peritonei (PMP), which currently lacks effective drug treatments, we screened extracts of marine actinomycete bacteria against the PMP cell line ABX023-1. This effort led to the isolation of nine rearranged angucyclines from Streptomyces sp. CNZ-748, including five new analogues, namely, grincamycins P–T (1–5). The chemical structures of these compounds were unambiguously established based on spectroscopic and chemical analyses. Particularly, grincamycin R (3) possesses an S-containing α-l-methylthio-aculose residue, which was discovered in nature for the first time. All of the isolated compounds were evaluated against four PMP cell lines and some exhibited low micromolar inhibitory activities. To identify a candidate biosynthetic gene cluster (BGC) encoding the grincamycins, we sequenced the genome of the producing strain, Streptomyces sp. CNZ-748, and compared the BGCs detected with those linked to the production of angucyclines with different aglycon structures.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jnatprod.1c00179?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jnatprod.1c00179</a>.Strain taxonomy of CNZ-748; BGC annotation; HPLC chromatogram of extract; UV, HRMS, and 1D and 2D NMR spectra of 1–9; and cytotoxicity assay results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.1c00179/suppl_file/np1c00179_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Cytotoxic Angucycline Class Glycosides from the Deep Sea Actinomycete Streptomyces Lusitanus SCSIO LR32.

Grincamycins I - K, Cytotoxic Angucycline Glycosides Derived from Marine-Derived Actinomycete Streptomyces lusitanus SCSIO LR32.

Cytotoxic Antibiotic Angucyclines and Actinomycins from the Streptomyces Sp. XZHG99T

Antibiotic Angucycline Derivatives from the Deepsea-Derived Streptomyces Lusitanus

Cytotoxic and Antibacterial Angucycline- and Prodigiosin- Analogues from the Deep-Sea Derived Streptomyces sp. SCSIO 11594

Monacycliones G-K and Ent-Gephyromycin A, Angucycline Derivatives from the Marine-Derived Streptomyces Sp. HDN15129.

Angucycline Glycosides from an Intertidal Sediments Strain Streptomyces sp. and Their Cytotoxic Activity against Hepatoma Carcinoma Cells

Cytotoxic Angucyclines Fromamycolatopsissp. HCa1, a Rare Actinobacteria Derived Fromoxya Chinensis

Deciphering the Glycosylation Steps in the Biosynthesis of P-1894B and Grincamycin Isolated from Marine-Derived Streptomyces lusitanus SCSIO LR32

Cytotoxic, Anti-Migration, and Anti-Invasion Activities on Breast Cancer Cells of Angucycline Glycosides Isolated from a Marine-Derived Streptomyces Sp.

Cangumycins A-F, Six New Angucyclinone Analogues with Immunosuppressive Activity from Streptomyces.

Cytotoxic Bafilomycin Analogues 6/5/5 with Tricyclic Ring System from a Marine-Derived Streptomyces Sp

Two glucosylated angucyclines from deep-sea-derived Streptomyces sp.PKU-MA01297

Angucycline antibiotics and its derivatives from marine-derived actinomycete Streptomyces sp. A6H

Grincamycins P–T: Rearranged Angucyclines from the Marine Sediment-Derived Streptomyces sp. CNZ-748 Inhibit Cell Lines of the Rare Cancer Pseudomyxoma Peritonei

Gephyyamycin and Cysrabelomycin, Two New Angucyclinone Derivatives from the Streptomyces Sp. HN-A124

Angucyclines and Angucyclinones from Streptomyces Sp. CB01913 Featuring C-Ring Cleavage and Expansion.

Three novel members of angucycline group from Streptomyces sp. N05WA963

ChemInform Abstract: Angucyclines from an Insect‐Derived Actinobacterium Amycolatopsis Sp. HCa1 and Their Cytotoxic Activity.

Kiamycin, A Unique Cytotoxic Angucyclinone Derivative From A Marine Streptomyces Sp.

Donghaecyclinones A–C: New Cytotoxic Rearranged Angucyclinones from a Volcanic Island-Derived Marine Streptomyces sp.